ArticleNeuro-oncology2025

High-throughput in vitro drug screening and in vivo studies identify fenretinide as a brain-penetrant DMG therapeutic.

Dannielle H Upton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.